Literature DB >> 23157789

Generalized flare of pustular psoriasis induced by PEGylated interferon-α2b therapy for chronic hepatitis C.

Meng-Chi Wu1, J Yu-Yun Lee.   

Abstract

New onset or exacerbation of psoriasis vulgaris has been reported in a small number of patients after interferon (IFN)-α therapy. Herein, we report a case of generalized flare of pustular psoriasis induced by PEGylated IFN-α2b (PEG-IFN-α2b) in a 59-year-old woman with a 15-year history of pustular psoriasis and chronic hepatitis C. Interferon-α therapy was discontinued and the rash resolved after treatment with cyclosporin and systemic methylprednisolone. The potential side effect of PEG-IFN-α2b in inducing or exacerbating psoriasis should be kept in mind when treating patients with a history of psoriasis or pustular psoriasis.
© 2011 The Authors. Australasian Journal of Dermatology © 2011 The Australasian College of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 23157789     DOI: 10.1111/j.1440-0960.2011.00767.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  3 in total

Review 1.  Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.

Authors:  M Afshar; A D Martinez; R L Gallo; T R Hata
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-01       Impact factor: 6.166

Review 2.  Peginterferon alfa related psoriasis in a patient with acute hepatitis C and review of the literature.

Authors:  Muhammed Sait Dag; Zeynel Abidin Oztürk; Nimet Yılmaz; Hakan Cam; Abdurrahman Kadayıfçı
Journal:  Wien Klin Wochenschr       Date:  2013-08-03       Impact factor: 1.704

3.  Interferon Kappa Is Up-Regulated in Psoriasis and It Up-Regulates Psoriasis-Associated Cytokines in vivo.

Authors:  Yuanyuan Li; Yueqi Song; Leqing Zhu; Xiao Wang; Bin Yang; Ping Lu; Quan Chen; Lianghua Bin; Liehua Deng
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.